Synthesis, antifungal activity, and molecular docking studies of novel triazole derivatives

Medicinal Chemistry

Volumn 9, Issue 3, 2013, Pages 384-388

  Wang, Nan ^a   Chai, Xiaoyun ^b   Chen, Ying ^a   Zhang, Lei ^a   Li, Wenjuan ^a   Gao, Yijun ^a   Bi, Yi ^a   Yu, Shichong ^b   Meng, Qingguo ^a  

^a YANTAI UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antifungal activity; Carbonate; Molecular docking; Synthesis; Triazole

Indexed keywords

ANTIFUNGAL AGENT; STEROL 14ALPHA DEMETHYLASE; TRIAZOLE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIFUNGAL AGENTS; CATALYTIC DOMAIN; DRUG DESIGN; FUNGI; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; MOLECULAR STRUCTURE; TRIAZOLES;

EID: 84877981921     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/1573406411309030009     Document Type: Article

References (22)

1. Singh, N. Safety of lactobacillus strains used as probiotic agents with reply. Clin. Infect. Dis. 2001, 33, 1692-1696.
2. Richardson, M. D. Changing patterns and trends in systemic fungal infections. J. Antimicrob. Chemother. 2005, 56, i5-i11.
3. Hobson, R.P. The global epidemiology of invasive Candida infections is the tide turning? J. Hosp. Infect. 2003, 55, 159-168.
4. Slavin, M.A.; Gattlieb, T.; Chen, S.; Sorrell, T.; Spelman, D.; Shaw, D.; Franklin, C.; Rowland, K.; Looke, D.; Whitby, M.; Nimmo, G.; Cooley, L.; Mayall, B.; Speed, B.; Shoerey, H.; Joyce, L.; Byrnes, G.; Ellis, D. The epidemiology of candidaemia and mould infections in Australia. J. Antimicrob. Chemother. 2002, 49(Suppl1): 3-6.
5. Wingard, J. R.; Leather, H. Biol. A new era of antifungal therapy. Blood Marrow Transplant. 2004, 10 (2), 73-90.
6. Fridkin, S. K.; Jarvis, W. R. Epidemiology of nosocomial fungal infections. Clin. Microbiol. Rev. 1996, 9 (4), 499-511.
7. Gallis, H. A.; Drew, R. H.; Pickard, W. W. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 1990, 12, 308-329.
8. Sheehan, D. J.; Hitchcock, C. A.; Sibley, C. M. Current and emerging azole antifungal agents. Clin. Microbiol. Rev. 1999, 12 (1), 40- 79.
9. Denning, D. W. Echinocandins: a new class of antifungal. J. Antimicrob. Chemother. 2002, 49 (6), 889-891.
10. Aoyama, Y.; Yoshida, Y.; Sato, R. Yeast cytochrome P-450 catalyzing lanosterol 14 alpha-demethylation. II. Lanosterol metabolism by purified P-450(14)DM and by intact microsomes. J. Biol. Chem. 1984, 259, 1661-1666.
11. Lamb, D. C.; Kelly, D. E.; Venkateswarlu, K.; Manning, N. J.; Bligh, H. F.; Schunck, W. H.; Kelly, S. L. Generation of a complete, soluble, and catalytically active sterol 14 alpha- demethylasereductase complex. Biochemistry 1999, 38 (27), 8733-8738.
12. Georgopapadakou, N. H., Di Domenico, B. Novel antifungal drugs. Curr. Opin. Microbiol. 1998, 1, 547-557.
13. Lupetti, A.; Danesi, R.; Campa, M.; Tacca, M. D.; Kelly, S. Molecular basis of resistance to azole antifungals. Trends in Mol. Med. 2002, 8, 76-81.
14. Rogers, T. R. Antifungal drug resistance: does it matter?. Int. J. Infect. Dis. 2002, 6(Suppl 1), S47-53.
15. Perlin, D. S. Resistance to echinocandin-class antifungal drugs. Drug Resistance Updates. 2007, 10(3), 121-130.
16. Chai, X.; Zhang, J.; Hu, H.; Yu, S.; Sun, Q.; Zhang, D.; Jiang, Y.; Wu, Q. Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14α- demethylase. Eur. J. Med. Chem. 2009, 44(5), 1913-1920.
17. Sheng, C.; Zhang, W.; Ji, H.; Song, Y.; Zhang, M.; Zhou, Y.; Lu, J.; Zhu, J. 3D-QSAR-of a series of novel triazole antifungi compounds. Chin. Chem. Lett. 2004, 15(4), 404-407.
18. Chai, X.; Zhang, J.; Yu, S.; Hu, H.; Zou, Y.; Zhao, Q.; Dan, Z.; Zhang, D.; Wu, Q. Design, synthesis, and biological evaluation of novel 1-(1H -1, 2, 4 -triazole-1 -yl)- 2-(2, 4- difluorophenyl)- 3- substituted benzylamino-2- propanols. Bioorg. Med. Chem. Lett. 2009, 19, 1811-1814.
19. Aoyama, Y.; Yoshida, Y.; Sonoda, Y.; Sato, Y. Metabolism of 32- hydroxy- 24, 25- dihydrolanosterol by purified cytochrome P- 45014DM from yeast. Evidence for contribution of the cytochrome to whole process of lanosterol 14 alpha-demethylation. J. Biol. Chem. 1987, 262, 1239-1243.
20. + 461.09.
21. Sheng, C.Q.; Zhang, W.N.; Ji, H.T.; Zhang, M.; Song, Y.L.; Xu, H.; Zhu, J.; Miao, Z.Y.; Jiang, Q.F.; Yao, J.Z.; Zhou, Y.J.; Zhu, J.; Lv, J.G. Structure-Based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking. J. Med. Chem. 2006, 49(8), 2512-2525.
22. Guan, Z.; Chai, X.; Yu, S.; Hu, H.; Jiang, Y.; Meng, Q.; Wu, Q. Synthesis, molecular docking, and biological evaluation of novel triazole derivatives as antifungal agents. Chem. Biol. Drug Des. 2010, 76(6), 496-504.